Furthermore, tumors from the treatment group exhibited reduced proliferative activity, as indicated by diminished Ki‐67 expression (Figure 6m,n), suggesting that modulation of the immune microenvironment may contribute to the observed tumor suppression. The gene discussed is MKI67; the disease is neoplasm.